SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment.

SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment – Cell Metabolism

Related: Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? – The Lancet Diabetes & Endocrinology

Commentary on Twitter

A new report reinforces the capability for #SARSCoV2 to infect and kill pancreatic β-islet cells, affect insulin secretion https://t.co/4tpIVNpjTf @Cell_Metabolism #diabetes @StanfordMed @stanfordimmuno @UCSF and collaborators pic.twitter.com/dG027CXS5e

— Eric Topol (@EricTopol) May 18, 2021